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1. Introduction 
An NADPH-cytochrome c reductase activity was 
observed in microsome particles from several 
mammalian tissues [l-S] , anaerobically grown yeast 
[6] and housefly (Larvae) [7]. Hepatic microsomal 
flavoprotein, NADPH-cy;ochrome c reductase 
(NADPH: cytochrome c oxidoreductase, EC 1.6.99.2) 
which contains one to two molecules of FAD per mol- 
ecule of enzyme has been purified [ 1,8,9] . However, 
the reductase from rabbit or pig microsomes was re- 
examined as flavoprotein containing one mole each of 
FAD and of FMN per mole enzyme [lo] and the two 
flavines have nonidentical properties from the data of 
the oxidation-reduction reactions [ 10,l l] . The ac- 
tive mixed-function oxidase system has been recon- 
stituted from microsomal fractions containing 
NADPH-cytochrome c reductase and cytochrome 
P-450 [ 12,131. No evidence for the existence of an 
iron-sulfur protein of adrendoxin and putidaredoxin 
or non-heme iron protein of rubredoxin type has been 
obtained in the hepatic microsomes [ 14,151. A possi- 
ble functional role of each flavine in hepatic enzyme 
has been discussed [ 1 l] . It is, therefore, important to 
compare the characteristics of kidney cortex and sple- 
nit microsomal NADPH-cytochrome c reductase with 
those of hepatic NADPH-cytochrome c reductase 
(NADPH-cytochrome P-450 reductase). 
The present paper provides evidence that a purified 
NADPH-cytochrome c reductase prepared by trypsin 
solubilization and chromatography from kidney cortex 
and splenic microsomes contained one mole each of 
FAD and of FMN per protein molecule. O2 -stable 
semiquinone with distinctive absorption spectrum was 
obtained by reduction with NADPH in the presence of 
North-Holland Publishing Company - Amsterdam 
oxygen and not completely reduced by excess NADPH. 
These results obtained with kidney and splenic enzyme 
were very similar to those of hepatic NADPH-cyto- 
chrome c reductase [lo] , and suggest hat kidney 
cortex and splenic microsomal NADPH-cytochrome 
c reductase have properties and functions similar to 
those of hepatic enzyme. 
2. Materials and methods 
Fresh pig kidney cortex and spleen were homo- 
genized for a total of 5 min in four volumes of ice- 
cold 0.15 M KC1 and fractionated by differential 
centrifugation [lo] . Pig kidney cortex and splenic 
NADPH-cytochrome c reductase were prepared by the 
same method described elsewhere [lo] . Yield of the 
purified reductase was about 1 O-20% of microsomal 
activity. NADH- and NADPH-cytochrome c reductase 
activities were determined by the method of Omura 
and Takesue [9] . Flavin content was determined by 
the method of Iyanagi and Mason [lo] , using 
phosphodiesterase and apoflavodoxin. Enzyme con- 
centration expressed as flavine concentration was 
determined spectrophotometrically, using E 455 = 
10.7 mM_’ cm-’ [lo] . All chemicals and reagents 
were of standard reagent grades obtained from commer- 
cial sources. 
3. Results 
The molecular weight of trypsin-solubilized NADPH- 
cytochrome c reductase from pig kidney cortex and 
splenic microsomes has been estimated to be 66 000, 
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Table 1 
FMN and FAD of kidney cortex and splenic microsomal NADPH-cytochrome c 
reductase, estimated with phosphodiesterase and Apo-flavodoxin 
Sample Initial fluori- 
metric reading 
at 520 nm 
Reading after 
phospho- 
diesterase 
addition 
(0.8 mg/ml) 
Reading after 
apo-flavodoxin 
addition 
(2 x 1O-6 M) 
D-Amino acid oxidase 
(1.0 x 1O-6 M) 
7.2 77.0 1.8 
Kidney NADPH-cyt.c. 
reductase 
(0.95 x 1O-6 M) 
38.2 71.0 1.3 
37.8 Not treated 4.7 
Splenic NADPH-cyt.c 
reductase 
(1.0 X 1O-6 M) 
37.7 76.2 2.3 
Flavine solutions from D-amino acid oxidase and NADPH-cytochrome c reductase were 
prepared by the method of Mayhew and Massey [ 161. Fluorescence was measured at 520 nm 
(emission) and 445 nm (excitation) in 0.02 M Na-acetate buffer, pH 6.0 (containing 0.2 M 
NaCl). 
by using the gel filtration method with Sephadex G-100. 
The pH optimum of NADPH-cytochrome c reductase 
activity was in the range of pH 8-9. The Km values for 
NADPH and NADH were 3.3 X 10e6 M, 4 X 10W2 M 
(kidney) and 4.7 X 10” M, 5 X 10m2 M (spleen), respec- 
tively. The Km values for cytochrome c were 9.5 X 10e6 
M (kidney), 6.0 X 10” M (spleen). 
The flavin of purified NADPH-cytochrome c 
reductase was analyzed using phosphodiesterase and 
apoflavodoxin. The addition of snake venom phospho- 
diesterase to total flavine released by the method of 
Mayhew and Massey [ 161 from NADPH-cytochrome 
c reductase resulted in increase of 1.86 (kidney) and 
2.0 (spleen) in fluorescence at 520 nm; that is, 
fluorescence due to FMN upon hydrolysis of FAD. 
Furthermore, addition of 2-fold excess of apoflavodoxin 
to the phosphodiesterase-treated flavines resulted in 
decrease of about 50-fold in fluorescence at 520 nm. 
These results (table 1) as well as the results obtained 
in hepatic NADPH-cytochrome c reductase indicate 
that kidney cortex and splenic microsomal NADPH- 
cytochrome c reductase contained FAD and FMN in 
about equimolar quantities. 
Fig. 1 depicts the visible absorption spectrum of 
purified kidney NADPH-cytochrome c reductase. The 
oxidized enzyme has absorption peaks at 455 nm and 
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3.80 nm. The absorption spectrum of the stable 
semiquionone was obtained at the NADPH addition in 
the presence of air. This distinctive spectrum (fig. 1: 
curve B) is similar to that obtained with hepatic 
reductase [lo] . The stable semiquinone form was not 
0.3 
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Fig. 1. Absorption spectra of purified kidney NADPH- 
cytochrome c reductase. The stable semiquinone was 
prepared by adding NADPH (66 PM, final concentration) 
in the presence of air to purified enzyme (20 PM) in 0.1 M 
potassium phosphate buffer (pH 7.7): curve A, oxidized: 
curve B, stable semiquinone form: curve C, after NADPH 
(660 PM, final concentration) under anaerobic conditions: 
curve D, hydrosulfite reduced form. 
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completely reduced by excess NADPH (fig. 1: curve 
C). Almost identical results were also obtained in 
splenic NADPH-cytochrome c reductase. 
4. Discussion 
The electron transfer system of the hepatic mi- 
crosomal cytochrome P-450 mixed function oxidase 
differs from Pseudomonas putida and adrenal mito- 
chondria containing the reductase, non-heme iron 
protein and P-450; namely, iron-sulfur protein with a 
g= 1.94 signal is not detected in hepatic microsomes 
[ 14,151 . In addition, differences in oxidation-reduction 
reactions between microsomal NADPH-cytochrome c 
reductase and adrenodoxin reductase or putidaredoxin 
reductase have been reported, e.g., hepatic microsomal 
reductase forms the stable semiquinone form during 
the titration of the oxidized enzyme by NADPH or 
sodium dithionite [ 1 l] but adrenodoxin reductase 
does not form a stable semiquione [ 171. Adrenodoxin 
and putidaredoxin reductase [ 17,181, which contain 
FAD as a prosthetic group, do not react with cyto- 
chrome c but react with it only in the presence of 
non-heme iron protein [ 171. These reductases play a 
similar role in electron transfer, as follows [21,22] , 
NAD(P)H -+ fp (FAD) -+ non-heme iron protein 
+ P-450 
The results of the reconstitution of mixed function 
oxidase show that the hepatic NADPH-cytochrome 
c reductase fraction can replace kidney reductase [2] 
or yeast reductase fractions [ 191. Furthermore, 
NADPH-cytochrome c reductase activity in spleen 
microsomes is inhibited by liver anti-NADPH-cyto- 
chrome c reductase y-globulin [3]. These results 
suggest hat these reductases have very similar 
properties in structure and function. 
Electron transfer components in microsomes are 
summarized in table 2. This table suggests that the 
same cytochrome P-450 reductase system operates 
in microsomes. Adrenodoxin [20,21] and putidare- 
doxin [22] are components of the electron transfer 
system containing P-450. However, microsomal 
system, which does not contain the non-heme iron 
protein [26] , may contain FMN instead of 
adrenodoxin and putidaredoxin. If microsomal 
NADPH-cytochrome c-reductase is directly involved 
in the microsomal reduction of cytochrome P-450 
during the mixed function oxidase cycle, it appears 
likely that the electron transfer sequence can be the 
following [ 111 . 
NADPH + fp (FAD = FMN) + P-450 
In this case, each flavine in hepatic, kidney and 
splenic NADPH-cytochrome c reductase may have an 
individual function, that is, one flavine accepts two 
reducing equivalents from NADPH and the other acts 
as a one-electron carrier in the electron transfer from 
NADPH to cytochrome P-450. The low potential state 
(-37 1 mV) [ 1 l] of flavin in the microsomal NADPH- 
cytochrome c reductase may act as non-heme protein 
Table 2 
The electron transfer components in microsomes 
Source of 
microsomes 
NADPH-cyt. c reduc- 
tase activity 
(nmoles/min per mg 
of protein) 
Prosthetic 
group of 
NADPH-Cyt.c 
reductase 
P-450 Cyt. b, 
Liver 209 [lo] FAD, FMN [lO,llj + + 
Kidney 30-38 [24] FAD, FMN [This paper] + 
Spleen 3.3 [3] FAD, FMN [ ‘Ihis paper] + (1) 
Thyroid 4.7 (251 ? Peroxidase* * + 
Yeast + ]191 (FAD, FMN)* + + 
Housefly (Larvae) 53.3 [7] ? + + 
* Although the localization within the cell is not clear, the isolation of NADPH-cytochrome c reductase from 
yeast is reported [23]. 
** The existence of cytochrome P-450 is not reported, but contain peroxidase [4]. 
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in the microsomal electron transport system. That is, [Ill 
it probably functions as a univalent carrier operating 
between the semiquinone and fully reduced forms [ 161. [I21 
Acknowledgement 
The author thanks Dr S. G. Mayhew for generous 
gifts of Pseudomonas elesdenii flavodoxin. 
References 
[ 11 Williams, C. H. and Kamin, H. (1962) J. Biol. Chem. 
237,587-595. 
[2] Ichihara, K., Kusunose, E. and Kusunose, M. (1973) 
Eur. J. Biochem. 38,463-472. 
[3] Schacter, B. A., Nelson, E. B., Marver, H. S. and 
Masters, B. S. S. (1972) J. Biol. Chem. 274, 3601-3607. 
[4] Hosoya, T., Matsukawa, S. and Nagai, Y., (1971) Bio- 
chemistry 10, 3086-3093. 
[5] Schacter, B. A., and Mason, J. I., (1974) Arch. Biochem. 
Biophys, 160, 274-278. 
[6] Ishidate, K., Kawaguchi, K., Tagawa, K., and 
Hagihara, B., (1969) J. Biochem.(Tokyo), 65, 375-383. 
[ 71 Okada, Y., and Okunuki, K., (1969) J. Biochem. 
(Tokyo) 65, 581-596. 
[8] Nishibayashi-Yamashita, H., and Sato, R., (1970) J. 
Biochem. (Tokyo), 67, 199-210. 
[9] Omura, T., and Takesue, S., (1970) J. Biochem. (Tokyo) 
67, 249-257. 
[lo] Iyanagi, T., and Mason, H. S., (1973) Biochemistry, 12, 
2297-2308. 
[I31 
[I41 
[I51 
[I61 
1171 
[I81 
iI91 
[201 
1211 
WI 
~231 
~241 
[251 
[261 
Iyanagi, T., and Makino, N., and Mason, H. S., (1974) 
Biochemistry, 13, 1701-1800. 
Lu, A. Y. H., and Coon, M. J., (1968) J. Biol. Chem. 
243,1331-1332. 
Fujita, T., and Mannering, G. J., (1973) J. Biol. Chem. 
248, 8150-8156. 
Miyake, Y., Mason, H. S., and Landgraf, W., (1967) J. 
Biol. Chem. 242, 3933397. 
Peisch, J., and Blumberg, W. E., (1970) Proc. Natl. 
Acad. Sci. U.S. 67, 172. 
Mayhew, S. G., and Massey, V., (1969) J. Biol. Chem. 
244,794-802. 
Jan-Wen Chu., and Kimura, T., (1973) J. Biol. Chem. 
248, 2089-2094. 
Gunsahrs, I. C., (1968) Hoppe-Seyler’s Z. Physiol. Chem. 
349,161O. 
Duppel, W., Lebeault, J-M., and Coon, M. J., (1973) 
Eur. J. Biochem. 36, 583-592. 
Huang, J. J., and Kimura, T., (1973) Biochemistry, 
12,406-409. 
Omura, T., Sato, R., Cooper, D. Y., Rosenthal, O., and 
Estabrook, R. W. (1964) Fed. Proc. Fed. Amer. Sot. 
Exptl. Biol. 24, 1181-1189. 
Tyson, C. A., Lipscomb, J. D. and GunsaIus, I. C. (1972) 
J. Biol. Chem. 247, 5777-5784. 
Drysdale, G. R. (1966) Flavins and Flavoproteins, First 
International Conference, (E. C. Slater, ed.), Elsevier, 
Amsterdam, P. 159. 
Jakobsson, S., Grundin, R., and Thor, H., (1973) Arch. 
Biochem. Biophys. 158, 556-565. 
Suzuki, M. (1973) Iodine Metabolism and Thyroid 
Function, Hokkaido Univ Medical Library Series, Vol. 6, 
p. l-27. 
Montgomery, M. R., Clark, C. and Holtzman, J. L., 
(1974) Arch. Biochem. Biophys. 160, 113-118. 
54 
